Generic Name and Formulations:
Permethrin 5%; crm.
Various generic manufacturers
Indications for Permethrin:
Adults and Children:
<2 months: not recommended. ≥2 months: massage into skin from head to soles of feet. Remove 8–14hrs later by washing. Usually 1 treatment suffices; if living mites are present after 14 days, retreat. Infants: also treat scalp, temples and forehead. Wash or dryclean bedding and clothing appropriately.
Allergy to pyrethrins, pyrethroids, or chrysanthemums.
Avoid eyes. Pregnancy (Cat.B). Nursing mothers: not recommended.
Pruritus, burning, stinging, tingling, numbness, erythema, rash.
Formerly known under the brand names Acticin, Elimite.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma
- NSCLC: Pretreatment Weight Loss May Be Linked to Socioeconomic Status
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- Atezolizumab, Carboplatin, Nab-Paclitaxel Combination Prolongs PFS in NSCLC